Recent findings from the human proteome project: opening the mass spectrometry toolbox to advance cancer diagnosis, surveillance and treatment

References

• Legrain P, Aebersold R, Archakov A, et al. The human proteome project: current state and future direction. Mol Cell Proteomics 2011;10(7):p M111 009993
   Web of Science ®Google Scholar
• Archakov A, Zgoda V, Kopylov A, et al. Chromosome-centric approach to overcoming bottlenecks in the Human Proteome Project. Expert Rev Proteomics 2012;9(6):667-76
   PubMed Web of Science ®Google Scholar
• Paik YK, Jeong SK, Omenn GS, et al. The Chromosome-Centric Human Proteome Project for cataloging proteins encoded in the genome. Nat Biotechnol 2012;30(3):221-3
   PubMed Web of Science ®Google Scholar
• Omenn GS, Menon R, Zhang Y. Innovations in proteomic profiling of cancers: alternative splice variants as a new class of cancer biomarker candidates and bridging of proteomics with structural biology. J Proteomics 2013;90:28-37
   PubMed Web of Science ®Google Scholar
• Aebersold R, Bader GD, Edwards AM, et al. Highlights of B/D-HPP and HPP Resource Pillar Workshops at 12th Annual HUPO World Congress of Proteomics: September 14-18, 2013, Yokohama, Japan. Proteomics 2014;14(9):975-88
   PubMed Web of Science ®Google Scholar
• Wang K, Huang C, Nice E. Recent advances in proteomics: towards the human proteome. Biomed Chromatogr 2014;28(6):848-57
   PubMed Web of Science ®Google Scholar
• Aebersold R, Bader GD, Edwards AM, et al. The biology/disease-driven human proteome project (B/D-HPP): enabling protein research for the life sciences community. J Proteome Res 2013;12(1):23-7
   PubMed Web of Science ®Google Scholar
• Berglund L, Björling E, Oksvold P, et al. A genecentric Human Protein Atlas for expression profiles based on antibodies. Mol Cell Proteomics 2008;7(10):2019-27
   PubMed Web of Science ®Google Scholar
• Hood LE, Omenn GS, Moritz RL, et al. New and improved proteomics technologies for understanding complex biological systems: addressing a grand challenge in the life sciences. Proteomics 2012;12(18):2773-83
   PubMed Web of Science ®Google Scholar
• Uhlén M, Fagerberg L, Hallström BM, et al. Proteomics. Tissue-based map of the human proteome. Science 2015;347(6220):1260419
   PubMed Web of Science ®Google Scholar
• HUPO. H.P.O, Biology/Disease-driven Human Proteome Project. 2014. HUPO Available from: http://www.thehpp.org/BD-HPP.php
   Google Scholar
• Vizcaino JA, Côté RG, Csordas A, et al. The PRoteomics IDEntifications (PRIDE) database and associated tools: status in 2013. Nucleic Acids Res 2013;41: Database issue D1063-9
   PubMed Web of Science ®Google Scholar
• Das J, Fragoza R, Lee HR, et al. Exploring mechanisms of human disease through structurally resolved protein interactome networks. Mol Biosyst 2014;10(1):9-17
   PubMedGoogle Scholar
• Vidal M, Cusick ME, Barabasi AL. Interactome networks and human disease. Cell 2011;144(6):986-98
   PubMed Web of Science ®Google Scholar
• Marcucci F, Bellone M, Caserta CA, Corti A. Pushing tumor cells towards a malignant phenotype: stimuli from the microenvironment, intercellular communications and alternative roads. Int J Cancer 2014;135(6):1265-76
   PubMed Web of Science ®Google Scholar
• Marusyk A, Almendro V, Polyak K. Intra-tumour heterogeneity: a looking glass for cancer? Nat Rev Cancer 2012;12(5):323-34
   PubMed Web of Science ®Google Scholar
• Marusyk A, Tabassum DP, Altrock PM, et al. Non-cell-autonomous driving of tumour growth supports sub-clonal heterogeneity. Nature 2014;514(7520):54-8
   PubMed Web of Science ®Google Scholar
• Ferlay J, Soerjomataram I, Dikshit R, et al. Cancer incidence and mortality worldwide: Sources, methods and major patterns in GLOBOCAN 2012. Int J Cancer 2015;136(5):E359-86
   PubMed Web of Science ®Google Scholar
• Russnes HG, Lønning PE, Børresen-Dale AL, Lingjærde OC. The multitude of molecular analyses in cancer: the opening of Pandora’s box. Genome Biol 2014;15(9):447
   PubMed Web of Science ®Google Scholar
• Leiserson MD, Blokh D, Sharan R, et al. Simultaneous identification of multiple driver pathways in cancer. PLoS Comput Biol 2013;9(5):e1003054
   Web of Science ®Google Scholar
• Barabasi AL, Gulbahce N, Loscalzo J. Network medicine: a network-based approach to human disease. Nat Rev Genet 2011;12(1):56-68
   PubMed Web of Science ®Google Scholar
• Foulkes WD. BRCA1 and BRCA2 - update and implications on the genetics of breast cancer: a clinical perspective. Clin Genet 2014;85(1):1-4
   PubMed Web of Science ®Google Scholar
• Welcsh PL, King MC. BRCA1 and BRCA2 and the genetics of breast and ovarian cancer. Hum Mol Genet 2001;10(7):705-13
   PubMed Web of Science ®Google Scholar
• Anderson L. Six decades searching for meaning in the proteome. J Proteomics 2014;107:24-30
   PubMed Web of Science ®Google Scholar
• Stamey TA, Yang N, Hay AR, et al. Prostate-specific antigen as a serum marker for adenocarcinoma of the prostate. N Engl J Med 1987;317(15):909-16
   PubMed Web of Science ®Google Scholar
• Catalona WJ, Richie JP, Ahmann FR, et al. Comparison of digital rectal examination and serum prostate specific antigen in the early detection of prostate cancer: results of a multicenter clinical trial of 6,630 men. J Urol 1994;151(5):1283-90
   PubMed Web of Science ®Google Scholar
• Li D, Chan DW. Proteomic cancer biomarkers from discovery to approval: it’s worth the effort. Expert Rev Proteomics 2014;11(2):135-6
   PubMed Web of Science ®Google Scholar
• Fuzery AK, Levin J, Chan MM, Chan DW. Translation of proteomic biomarkers into FDA approved cancer diagnostics: issues and challenges. Clin Proteomics 2013;10(1):13
   PubMed Web of Science ®Google Scholar
• Huttenhain R, Soste M, Selevsek N, et al. Reproducible quantification of cancer-associated proteins in body fluids using targeted proteomics. Sci Transl Med 2012;4(142):142ra94
   PubMed Web of Science ®Google Scholar
• Schiess R, Wollscheid B, Aebersold R. Targeted proteomic strategy for clinical biomarker discovery. Mol Oncol 2009;3(1):33-44
   PubMed Web of Science ®Google Scholar
• Albar J. Potential colon cancer biomarkers. Available from: https://db.systemsbiology.net/sbeams/cgi/PeptideAtlas/proteinList?protein_list_id=3
   Google Scholar
• Nice E. Potential Colorectal Cancer Biomarkers. Proteins implicated as potential Colo-rectal cancer biomarkers]. Available from: https://db.systemsbiology.net/sbeams/cgi/PeptideAtlas/proteinList?protein_list_id=4
   Google Scholar
• Zhang J, Wang K, Zhang J, et al. Using proteomic approach to identify tumor-associated proteins as biomarkers in human esophageal squamous cell carcinoma. J Proteome Res 2011;10(6):2863-72
   PubMed Web of Science ®Google Scholar
• Reis H, Pütter C, Megger DA, et al. A structured proteomic approach identifies 14-3-3Sigma as a novel and reliable protein biomarker in panel based differential diagnostics of liver tumors. Biochim Biophys Acta 2015;1854(6):641-50
   PubMed Web of Science ®Google Scholar
• Yu L, Shen J, Mannoor K, et al. Identification of ENO1 as a potential sputum biomarker for early-stage lung cancer by shotgun proteomics. Clin Lung Cancer 2014;15(5):372-8; e1
   PubMed Web of Science ®Google Scholar
• Cantor D, Slapetova I, Kan A, et al. Overexpression of alphavbeta6 integrin alters the colorectal cancer cell proteome in favor of elevated proliferation and a switching in cellular adhesion that increases invasion. J Proteome Res 2013;12(6):2477-90
   PubMed Web of Science ®Google Scholar
• Sun Q, Sun F, Wang B, et al. Interleukin-8 promotes cell migration through integrin alphavbeta6 upregulation in colorectal cancer. Cancer Lett 2014;354(2):245-53
   PubMed Web of Science ®Google Scholar
• Osawa T, Tsuchida R, Muramatsu M, et al. Inhibition of histone demethylase JMJD1A improves anti-angiogenic therapy and reduces tumor-associated macrophages. Cancer Res 2013;73(10):3019-28
   PubMed Web of Science ®Google Scholar
• Harlan R, Zhang H. Targeted proteomics: a bridge between discovery and validation. Expert Rev Proteomics 2014;11(6):657-61
   PubMed Web of Science ®Google Scholar
• Surinova S, Schiess R, Hüttenhain R, et al. On the development of plasma protein biomarkers. J Proteome Res 2011;10(1):5-16
   PubMed Web of Science ®Google Scholar
• Addona TA, Shi X, Keshishian H, et al. A pipeline that integrates the discovery and verification of plasma protein biomarkers reveals candidate markers for cardiovascular disease. Nat Biotechnol 2011;29(7):635-43
   PubMed Web of Science ®Google Scholar
• Lange V, Picotti P, Domon B, et al. Selected reaction monitoring for quantitative proteomics: a tutorial. Mol Syst Biol 2008;4:222
   PubMed Web of Science ®Google Scholar
• Picotti P, Rinner O, Stallmach R, et al. High-throughput generation of selected reaction-monitoring assays for proteins and proteomes. Nat Methods 2010;7(1):43-6
   PubMed Web of Science ®Google Scholar
• Addona TA, Abbatiello SE, Schilling B, et al. Multi-site assessment of the precision and reproducibility of multiple reaction monitoring-based measurements of proteins in plasma. Nat Biotechnol 2009;27(7):633-41
   PubMed Web of Science ®Google Scholar
• Timms JF, Arslan-Low E, Kabir M, et al. Discovery of serum biomarkers of ovarian cancer using complementary proteomic profiling strategies. Proteomics Clin Appl 2014;8(11-12):982-93
   PubMed Web of Science ®Google Scholar
• Polanski M, Anderson NL. A list of candidate cancer biomarkers for targeted proteomics. Biomark Insights 2007;1:1-48
   PubMedGoogle Scholar
• Dittrich J, Becker S, Hecht M, Ceglarek U. Sample preparation strategies for targeted proteomics via proteotypic peptides in human blood using liquid chromatography tandem mass spectrometry. Proteomics Clin Appl 2015;9(1-2):5-16
   PubMed Web of Science ®Google Scholar
• Farrah T, Deutsch EW, Kreisberg R, et al. PASSEL: the PeptideAtlas SRMexperiment library. Proteomics 2012;12(8):1170-5
   PubMed Web of Science ®Google Scholar
• Ang CS, Rothacker J, Patsiouras H, et al. Use of multiple reaction monitoring for multiplex analysis of colorectal cancer-associated proteins in human feces. Electrophoresis 2011;32(15):1926-38
   PubMed Web of Science ®Google Scholar
• Nice E. Biomarker discovery and validation: the tide is turning. Expert Rev Proteomics 2013;10(6):505-7
   PubMed Web of Science ®Google Scholar
• Farrah T, Deutsch EW, Omenn GS, et al. A high-confidence human plasma proteome reference set with estimated concentrations in PeptideAtlas. Mol Cell Proteomics 2011;10(9):M110; 006353
   Web of Science ®Google Scholar
• Kusebauch U, Deutsch EW, Campbell DS, et al. Using PeptideAtlas, SRMAtlas, and PASSEL: Comprehensive Resources for Discovery and Targeted Proteomics. Curr Protoc Bioinformatics 2014;46:13; 25 1-13 25 28
   PubMedGoogle Scholar
• Farrah T, Deutsch EW, Omenn GS, et al. State of the human proteome in 2013 as viewed through PeptideAtlas: comparing the kidney, urine, and plasma proteomes for the biology- and disease-driven Human Proteome Project. J Proteome Res 2014;13(1):60-75
   PubMed Web of Science ®Google Scholar
• Picotti P, Aebersold R. Selected reaction monitoring-based proteomics: workflows, potential, pitfalls and future directions. Nat Methods 2012;9(6):555-66
   PubMed Web of Science ®Google Scholar
• Bronsert P, Weißer J, Biniossek ML, et al. Impact of routinely employed procedures for tissue processing on the proteomic analysis of formalin-fixed paraffin-embedded tissue. Proteomics Clin Appl 2014;8(9-10):796-804
   PubMed Web of Science ®Google Scholar
• Tanca A, Abbondio M, Pisanu S, et al. Critical comparison of sample preparation strategies for shotgun proteomic analysis of formalin-fixed, paraffin-embedded samples: insights from liver tissue. Clin Proteomics 2014;11(1):28
   PubMedGoogle Scholar
• Wang LN, Tong SW, Hu HD, et al. Quantitative proteome analysis of ovarian cancer tissues using a iTRAQ approach. J Cell Biochem 2012;113(12):3762-72
   PubMed Web of Science ®Google Scholar
• Tauro BJ, Greening DW, Mathias RA, et al. Two distinct populations of exosomes are released from LIM1863 colon carcinoma cell-derived organoids. Mol Cell Proteomics 2013;12(3):587-98
   PubMed Web of Science ®Google Scholar
• Mukherjee S, Rodriguez-Canales J, Hanson J, et al. Proteomic analysis of frozen tissue samples using laser capture microdissection. Methods Mol Biol 2013;1002:71-83
   PubMedGoogle Scholar
• Swanton C, Caldas C. Molecular classification of solid tumours: towards pathway-driven therapeutics. Br J Cancer 2009;100(10):1517-22
   PubMed Web of Science ®Google Scholar
• Suehara Y, Kubota D, Saito T. Tissue sample preparation for biomarker discovery. Methods Mol Biol 2013;1002:13-23
   PubMedGoogle Scholar
• Bodenmiller B, Zunder ER, Finck R, et al. Multiplexed mass cytometry profiling of cellular states perturbed by small-molecule regulators. Nat Biotechnol 2012;30(9):858-67
   PubMed Web of Science ®Google Scholar
• Gillet LC, Navarro P, Tate S, et al. Targeted data extraction of the MS/MS spectra generated by data-independent acquisition: a new concept for consistent and accurate proteome analysis. Mol Cell Proteomics 2012;11(6):O111; 016717
   PubMed Web of Science ®Google Scholar
• Geiger T, Wehner A, Schaab C, et al. Comparative proteomic analysis of eleven common cell lines reveals ubiquitous but varying expression of most proteins. Mol Cell Proteomics 2012;11(3):M111; 014050
   Web of Science ®Google Scholar
• Moghaddas Gholami A, Hahne H, Wu Z, et al. Global proteome analysis of the NCI-60 cell line panel. Cell Rep 2013;4(3):609-20
   PubMed Web of Science ®Google Scholar
• Kim MS, Pinto SM, Getnet D, et al. A draft map of the human proteome. Nature 2014;509(7502):575-81
   PubMed Web of Science ®Google Scholar
• Wilhelm M, Schlegl J, Hahne H, et al. Mass-spectrometry-based draft of the human proteome. Nature 2014;509(7502):582-7
   PubMed Web of Science ®Google Scholar
• Michalski A, Cox J, Mann M. More than 100,000 detectable peptide species elute in single shotgun proteomics runs but the majority is inaccessible to data-dependent LC-MS/MS. J Proteome Res 2011;10(4):1785-93
   PubMed Web of Science ®Google Scholar
• Kiyonami R, Schoen A, Prakash A, et al. Increased selectivity, analytical precision, and throughput in targeted proteomics. Mol Cell Proteomics 2011;10(2):M110; 002931
   Web of Science ®Google Scholar
• Panchaud A, Jung S, Shaffer SA, et al. Faster, quantitative, and accurate precursor acquisition independent from ion count. Anal Chem 2011;83(6):2250-7
   PubMed Web of Science ®Google Scholar
• Rosenberger G, Chiek Koh C, Guo T, et al. A repository of assays to quantify 10,000 human proteins by SWATH-MS. Scientific Data 2014; 1
   Web of Science ®Google Scholar
• Liu Y, Chen J, Sethi A, et al. Glycoproteomic analysis of prostate cancer tissues by SWATH mass spectrometry discovers N-acylethanolamine acid amidase and protein tyrosine kinase 7 as signatures for tumor aggressiveness. Mol Cell Proteomics 2014;13(7):1753-68
   PubMed Web of Science ®Google Scholar
• Zhang F, Lin H, Gu A, et al. SWATH- and iTRAQ-based quantitative proteomic analyses reveal an overexpression and biological relevance of CD109 in advanced NSCLC. J Proteomics 2014;102:125-36
   PubMed Web of Science ®Google Scholar
• Held JM, Schilling B, D’Souza AK, et al. Label-Free Quantitation and Mapping of the ErbB2 Tumor Receptor by Multiple Protease Digestion with Data-Dependent (MS1) and Data-Independent (MS2) Acquisitions. Int J Proteomics 2013;2013:791985
   PubMedGoogle Scholar
• Herdering C, Reifschneider O, Wehe CA, et al. Ambient molecular imaging by laser ablation atmospheric pressure chemical ionization mass spectrometry. Rapid Commun Mass Spectrom 2013;27(23):2595-600
   PubMed Web of Science ®Google Scholar
• Ovchinnikova OS, Kertesz V, Van Berkel GJ. Combining transmission geometry laser ablation and a noncontact continuous flow surface sampling probe/electrospray emitter for mass spectrometry based chemical imaging. Rapid Commun Mass Spectrom 2011;25(24):3735-40
   PubMed Web of Science ®Google Scholar
• Wang HA, Grolimund D, Giesen C, et al. Fast chemical imaging at high spatial resolution by laser ablation inductively coupled plasma mass spectrometry. Anal Chem 2013;85(21):10107-16
   PubMed Web of Science ®Google Scholar
• Wang HA, Grolimund D, Van Loon LR, et al. Quantitative chemical imaging of element diffusion into heterogeneous media using laser ablation inductively coupled plasma mass spectrometry, synchrotron micro-X-ray fluorescence, and extended X-ray absorption fine structure spectroscopy. Anal Chem 2011;83(16):6259-66
   PubMed Web of Science ®Google Scholar
• Kriegsmann J, Kriegsmann M, Casadonte R. MALDI TOF imaging mass spectrometry in clinical pathology: a valuable tool for cancer diagnostics (review). Int J Oncol 2015;46(3):893-906
   PubMed Web of Science ®Google Scholar
• Schwartz SA, Caprioli RM. Imaging mass spectrometry: viewing the future. Methods Mol Biol 2010;656:3-19
   PubMedGoogle Scholar
• Rubakhin SS, Sweedler JV. A mass spectrometry primer for mass spectrometry imaging. Methods Mol Biol 2010;656:21-49
   PubMedGoogle Scholar
• Monroe EB, Annangudi SP, Hatcher NG, et al. SIMS and MALDI MS imaging of the spinal cord. Proteomics 2008;8(18):3746-54
   PubMed Web of Science ®Google Scholar
• Tucker KR, Serebryannyy LA, Zimmerman TA, et al. The modified-bead stretched sample method: development and application to MALDI-MS imaging of protein localization in the spinal cord. Chem Sci 2011;2(4):785-95
   PubMed Web of Science ®Google Scholar
• Schwartz SA, Weil RJ, Thompson RC, et al. Proteomic-based prognosis of brain tumor patients using direct-tissue matrix-assisted laser desorption ionization mass spectrometry. Cancer Res 2005;65(17):7674-81
   PubMed Web of Science ®Google Scholar
• Lemaire R, Desmons A, Tabet JC, et al. Direct analysis and MALDI imaging of formalin-fixed, paraffin-embedded tissue sections. J Proteome Res 2007;6(4):1295-305
   PubMed Web of Science ®Google Scholar
• Cornett DS, Mobley JA, Dias EC, et al. A novel histology-directed strategy for MALDI-MS tissue profiling that improves throughput and cellular specificity in human breast cancer. Mol Cell Proteomics 2006;5(10):1975-83
   PubMed Web of Science ®Google Scholar
• Yanagisawa K, et al. Proteomic patterns of tumour subsets in non-small-cell lung cancer. Lancet 2003;362(9382):433-9
   PubMed Web of Science ®Google Scholar
• Tomalova I, Foltynová P, Kanický V, Preisler J. MALDI MS and ICP MS detection of a single CE separation record: a tool for metalloproteomics. Anal Chem 2014;86(1):647-54
   PubMed Web of Science ®Google Scholar
• Hillenkamp F, Karas M. Mass spectrometry of peptides and proteins by matrix-assisted ultraviolet laser desorption/ionization. Methods Enzymol 1990;193:280-95
   PubMed Web of Science ®Google Scholar
• Edwards JL, Kennedy RT. Metabolomic analysis of eukaryotic tissue and prokaryotes using negative mode MALDI time-of-flight mass spectrometry. Anal Chem 2005;77(7):2201-9
   PubMed Web of Science ®Google Scholar
• Liu Q, Xiao Y, Pagan-Miranda C, et al. Metabolite imaging using matrix-enhanced surface-assisted laser desorption/ionization mass spectrometry (ME-SALDI-MS). J Am Soc Mass Spectrom 2009;20(1):80-8
   PubMed Web of Science ®Google Scholar
• Groseclose MR, Massion PP, Chaurand P, Caprioli RM. High-throughput proteomic analysis of formalin-fixed paraffin-embedded tissue microarrays using MALDI imaging mass spectrometry. Proteomics 2008;8(18):3715-24
   PubMed Web of Science ®Google Scholar
• Andersson M, Groseclose MR, Deutch AY, Caprioli RM. Imaging mass spectrometry of proteins and peptides: 3D volume reconstruction. Nat Methods 2008;5(1):101-8
   PubMed Web of Science ®Google Scholar
• Chen R, Hui L, Sturm RM, Li L. Three dimensional mapping of neuropeptides and lipids in crustacean brain by mass spectral imaging. J Am Soc Mass Spectrom 2009;20(6):1068-77
   PubMed Web of Science ®Google Scholar
• Crecelius AC, Cornett DS, Caprioli RM, et al. Three-dimensional visualization of protein expression in mouse brain structures using imaging mass spectrometry. J Am Soc Mass Spectrom 2005;16(7):1093-9
   PubMed Web of Science ®Google Scholar
• Djidja MC, Francese S, Loadman PM, et al. Detergent addition to tryptic digests and ion mobility separation prior to MS/MS improves peptide yield and protein identification for in situ proteomic investigation of frozen and formalin-fixed paraffin-embedded adenocarcinoma tissue sections. Proteomics 2009;9(10):2750-63
   PubMed Web of Science ®Google Scholar
• Becker JS, Zoriy M, Matusch A, et al. Bioimaging of metals by laser ablation inductively coupled plasma mass spectrometry (LA-ICP-MS). Mass Spectrom Rev 2010;29(1):156-75
   PubMed Web of Science ®Google Scholar
• Becker JS, Matusch A, Wu B. Bioimaging mass spectrometry of trace elements - recent advance and applications of LA-ICP-MS: A review. Anal Chim Acta 2014;835:1-18
   PubMed Web of Science ®Google Scholar
• Wu B, Becker JS. Imaging techniques for elements and element species in plant science. Metallomics 2012;4(5):403-16
   PubMed Web of Science ®Google Scholar
• Debeljak M, van Elteren JT, Vogel-Mikus K. Development of a 2D laser ablation inductively coupled plasma mass spectrometry mapping procedure for mercury in maize (Zea mays L.) root cross-sections. Anal Chim Acta 2013;787:155-62
   PubMed Web of Science ®Google Scholar
• Seuma J, Bunch J, Cox A, et al. Combination of immunohistochemistry and laser ablation ICP mass spectrometry for imaging of cancer biomarkers. Proteomics 2008;8(18):3775-84
   PubMed Web of Science ®Google Scholar
• Hare D, Burger F, Austin C, et al. Elemental bio-imaging of melanoma in lymph node biopsies. Analyst 2009;134(3):450-3
   PubMed Web of Science ®Google Scholar
• Chang Q, Ornatsky OI, Koch CJ, et al. Single-cell measurement of the uptake, intratumoral distribution and cell cycle effects of cisplatin using mass cytometry. Int J Cancer 2015;136(5):1202-9
   PubMed Web of Science ®Google Scholar
• Bendall SC, Simonds EF, Qiu P, et al. Single-cell mass cytometry of differential immune and drug responses across a human hematopoietic continuum. Science 2011;332(6030):687-96
   PubMed Web of Science ®Google Scholar
• Giesen C, Wang HA, Schapiro D, et al. Highly multiplexed imaging of tumor tissues with subcellular resolution by mass cytometry. Nat Methods 2014;11(4):417-22
   PubMed Web of Science ®Google Scholar
• Ruiz C, Lenkiewicz E, Evers L, et al. Advancing a clinically relevant perspective of the clonal nature of cancer. Proc Natl Acad Sci USA 2011;108(29):12054-9
   PubMed Web of Science ®Google Scholar
• Penchev VR, Rasheed ZA, Maitra A, Matsui W. Heterogeneity and targeting of pancreatic cancer stem cells. Clin Cancer Res 2012;18(16):4277-84
   PubMed Web of Science ®Google Scholar
• Russnes HG, Navin N, Hicks J, Borresen-Dale AL. Insight into the heterogeneity of breast cancer through next-generation sequencing. J Clin Invest 2011;121(10):3810-18
   PubMed Web of Science ®Google Scholar
• Kim MS, Zhong Y, Yachida S, et al. Heterogeneity of pancreatic cancer metastases in a single patient revealed by quantitative proteomics. Mol Cell Proteomics 2014;13(11):2803-11
   PubMed Web of Science ®Google Scholar
• Qiu P, Simonds EF, Bendall SC, et al. Extracting a cellular hierarchy from high-dimensional cytometry data with SPADE. Nat Biotechnol 2011;29(10):886-91
   PubMed Web of Science ®Google Scholar
• Turtoi A, Blomme A, Debois D, et al. Organized proteomic heterogeneity in colorectal cancer liver metastases and implications for therapies. Hepatology 2014;59(3):924-34
   PubMed Web of Science ®Google Scholar
• Cancer Genome Atlas Research N. Comprehensive molecular characterization of gastric adenocarcinoma. Nature 2014;513(7517):202-9
   PubMed Web of Science ®Google Scholar
• Nie W, Yan L, Lee YH, et al. Advanced mass spectrometry-based multi-omics technologies for exploring the pathogenesis of hepatocellular carcinoma. Mass Spectrom Rev 2014. [Epub ahead of print]
   PubMed Web of Science ®Google Scholar
• Abbatiello SE, Schilling B, Mani DR, et al. Large-scale inter-laboratory study to develop, analytically validate and apply highly multiplexed, quantitative peptide assays to measure cancer-relevant proteins in plasma. Mol Cell Proteomics 2015; Epub ahead of print
   PubMed Web of Science ®Google Scholar
• Malm J, Fehniger TE, Danmyr P, et al. Developments in biobanking workflow standardization providing sample integrity and stability. J Proteomics 2013;95:38-45
   PubMed Web of Science ®Google Scholar
• Eriksson C, Masaki N, Yao I, et al. MALDI imaging mass spectrometry-A mini review of methods and recent developments. Mass Spectrom (Tokyo) 2013;2(Spec Iss):S0022
   Google Scholar
• Alexandrov T. MALDI imaging mass spectrometry: statistical data analysis and current computational challenges. BMC Bioinformatics 2012;13(Suppl 16):S11
   PubMedGoogle Scholar
• Angel PM, Caprioli RM. Matrix-assisted laser desorption ionization imaging mass spectrometry: in situ molecular mapping. Biochemistry 2013;52(22):3818-28
   PubMed Web of Science ®Google Scholar
• Kawashima M, Iwamoto N, Kawaguchi-Sakita N, et al. High-resolution imaging mass spectrometry reveals detailed spatial distribution of phosphatidylinositols in human breast cancer. Cancer Sci 2013;104(10):1372-9
   PubMed Web of Science ®Google Scholar
• Schober Y, Guenther S, Spengler B, Römpp A. Single cell matrix-assisted laser desorption/ionization mass spectrometry imaging. Anal Chem 2012;84(15):6293-7
   PubMed Web of Science ®Google Scholar
• Gustafsson JO, Oehler MK, Ruszkiewicz A, et al. MALDI Imaging Mass Spectrometry (MALDI-IMS)-application of spatial proteomics for ovarian cancer classification and diagnosis. Int J Mol Sci 2011;12(1):773-94
   PubMed Web of Science ®Google Scholar
• Watrous JD, Dorrestein PC. Imaging mass spectrometry in microbiology. Nat Rev Microbiol 2011;9(9):683-94
   PubMed Web of Science ®Google Scholar
• Sabine Becker J. Imaging of metals in biological tissue by laser ablation inductively coupled plasma mass spectrometry (LA-ICP-MS): state of the art and future developments. J Mass Spectrom 2013;48(2):255-68
   PubMed Web of Science ®Google Scholar
• Angelo M, Bendall SC, Finck R, et al. Multiplexed ion beam imaging of human breast tumors. Nat Med 2014;20(4):436-42
   PubMed Web of Science ®Google Scholar